BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6838769)

  • 1. Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis.
    Walsdorfer U; Christophers E; Schröder JM
    Br J Dermatol; 1983 Apr; 108(4):451-6. PubMed ID: 6838769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil and monocyte chemotaxis in methotrexate-treated psoriasis patients.
    Ternowitz T; Herlin T
    Acta Derm Venereol Suppl (Stockh); 1985; 120():23-6. PubMed ID: 3869414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate inhibits the human C5a-induced skin response in patients with psoriasis.
    Ternowitz T; Bjerring P; Andersen PH; Schröder JM; Kragballe K
    J Invest Dermatol; 1987 Aug; 89(2):192-6. PubMed ID: 3598210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients.
    O'Callaghan JW; Forrest MJ; Brooks PM
    Rheumatol Int; 1988; 8(1):41-5. PubMed ID: 3363283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PMN migration measured by bottom filter counts in modified Boyden chambers. Chemokinetic deactivation and vinblastine inhibition of chemotaxis.
    Bandman U; Norberg B; Eriksson S
    Haematologia (Budap); 1986; 19(1):13-9. PubMed ID: 3721320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil chemotaxis in psoriasis before and after PUVA therapy.
    Guillot B; Guilhou JJ; Vendrel JP; Meynadier J
    Arch Dermatol Res; 1983; 275(1):19-22. PubMed ID: 6847241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis.
    Silny W; Pehamberger H; Zielinsky C; Gschnait F
    J Invest Dermatol; 1980 Aug; 75(2):187-8. PubMed ID: 6893337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphonuclear granulocyte chemotaxis and chemotactic factor generation by concanavalin A-stimulated peripheral blood mononuclear cells in patients with psoriasis.
    Csató M; Dobozy A; Hunyadi J; Kenderessy SA; Simon N
    Arch Dermatol Res; 1981; 271(3):259-64. PubMed ID: 7305440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG; Loken KI
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
    Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
    Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokinetic and chemotactic factors in psoriasis scale extracts.
    Dahl MV; Lindroos WE; Nelson RD
    J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of filter-bound IgA in inhibiting polymorphonuclear leukocyte chemotaxis.
    Schröder JM; Christophers E
    Immunobiology; 1983 Mar; 164(2):127-35. PubMed ID: 6852861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of MTX and BN52021 on PAF-induced chemotaxis of PMNs and intraepidermal accumulation of inflammatory cells in guinea pigs.
    Liu B; Zhang H; Li S; Chen W
    Chin Med J (Engl); 1996 Jun; 109(6):467-70. PubMed ID: 9206081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.